Genentech

Blood & Organ Banks · Massachusetts, United States · 1-10 Employees

View Company Info for Free

Overview

Headquarters

12 Michigan Dr, Natick, Massachusetts, 0...

Phone Number

(508) 651-9500

Revenue

<$5 Million

Industry

Blood & Organ Banks Business Services Healthcare Services Research & Development
ZI Rank: 3
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
3
2
4
4
3
3

About Genentech

Geneius Biotechnology specializes in the development and commercialization of innovative autologous, adoptive T-cell therapies aimed at providing a robust immune response to cancer. Their next-generation immunotherapy has demonstrated a 70% overall response rate and a 50% complete remission rate in clinical trials, with minimal side effects. The company focuses on precision immunotherapy, particularly for Epstein-Barr Virus (EBV+) lymphoma and solid tumors, offering a more accessible and cost-effective alternative to traditional CAR-T therapies. Geneius aims to transform cancer treatment by making advanced T-cell therapies available through community oncologists.Explore more
Genentech's Social MediaPopular SearchesGenentech IncGeneiusSIC Code 28,283NAICS Code 32,325Show more

Genentech Org Chart

AS
United States flag for contact location.

President, Chief Executive Officer & Founder ...

Flame icon indicating likelihood to engage via phone.PhoneFlame icon indicating likelihood to engage via email.Email
DK
United States flag for contact location.

Senior VP, Business Operations

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Is Genentech your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to Genentech

Compare insights from companies similar to Genentech, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Genentech

<$5M
1-10
Private
-
-
AS
Alfred SlanetzPresident, CEO & Founder & CEO
<$5M
11-50
Private
-
-
RB
Raymond BenoitCustomer Service and Data Entry
<$5M
11-50
Private
-
-
N/A
<$5M
1-10
Private
-
2009
N/A
<$5M
1-10
Private
-
-
AA
Anthony AshtonChief Scientific Officer
<$5M
1-10
Private
-
2011
LA
Larry AltstielChief Scientific Officer
<$5M
1-10
Private
-
2010
MV
Marina VoronchikhinaResearch Scientist
Illustration of an envelope

Company Profile Activity

i

Among all Healthcare Services companies

Low Activity

High Activity

Activity Insights

Genentech is experiencing very low activity levels compared to other companies in the Healthcare Services sector.

What does this means?

Genentech is drawing exceptional interest within the Healthcare Services industry, suggesting notable developments or strong market momentum, learn more about Genentech.

Genentech Tech Stack

A closer look at the technologies used by Genentech

Genentech News & Media

Read more news

Top Blood & Organ Banks Companies

Frequently Asked Questions Regarding Genentech

What is Genentech's official website?
Genentech's official website is www.geneiusbiotech.com
What is Genentech's Revenue?
Genentech's revenue is <$5 Million
What is Genentech's SIC code?
Genentech's SIC: 28,283
What is Genentech's NAICS code?
Genentech's NAICS: 32,325
How many employees does Genentech have?
Genentech has 1-10 employees
What industry does Genentech belong to?
Genentech is in the industry of: Blood & Organ Banks, Business Services, Healthcare Services
What is Genentech competition?
Genentech top competitors include: LightSeed, Pelican Therapeutics, Oncolyze, Persimmune
What technology does Genentech use?
Some of the popular technologies that Genentech uses are: Sectigo, The USERTRUST Network, Amazon CloudFront, Wix
How do I contact Genentech?
Genentech contact info: Phone number: (508) 651-9500 Website: www.geneiusbiotech.com
What does Genentech do?

Geneius Biotechnology specializes in the development and commercialization of innovative autologous, adoptive T-cell therapies aimed at providing a robust immune response to cancer. Their next-generation immunotherapy has demonstrated a 70% overall response rate and a 50% complete remission rate in clinical trials, with minimal side effects. The co... mpany focuses on precision immunotherapy, particularly for Epstein-Barr Virus (EBV+) lymphoma and solid tumors, offering a more accessible and cost-effective alternative to traditional CAR-T therapies. Geneius aims to transform cancer treatment by making advanced T-cell therapies available through community oncologists.Read More

What are Genentech social media links?
Genentech Linkedin page
Is Genentech a public company?
Genentech is private company therefore does not currently have an official ticker symbol
See more information about Genentech

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.